Search all trials

Find therapies in clinical trials near you – page 98

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Endometrial cancer

Not recruiting

Registered drug

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Loperamide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Prostate cancer recurrent

Not recruiting

Registered drug

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Tourette's disorder

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette's Disorder

InvestigationalNo placebo

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ecopipam Hydrochloride

Contact Research Centre

Hodgkin's disease

Not recruiting

Registered drugNo placebo

Study Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drug

Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

Registered drug

Poland

Participants:0–17 years
Substances:Ustekinumab

Contact Research Centre

Orthostatic hypotension

Not recruiting

Registered drug

Study on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Ampreloxetine

Contact Research Centre

Marginal zone lymphoma+1

Not recruiting

Registered drugNo placebo

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Crohn's disease

Not recruiting

Registered drug

Study on Ustekinumab for Children with Moderate to Severe Crohn's Disease

Registered drug

Poland

Participants:0–17 years
Substances:Ustekinumab

Contact Research Centre

Neurodermatitis

Not recruiting

Investigational

Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ruxolitinib

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Find therapies in clinical trials near you – page 98

1 208 trials match your criteria

Endometrial cancer

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Non-small cell lung cancer

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Malignant melanoma

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Prostate cancer recurrent

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Tourette's disorder

Study on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette's Disorder

Hodgkin's disease

Study Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Colitis ulcerative

Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

Orthostatic hypotension

Study on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

Marginal zone lymphoma+1

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Crohn's disease

Study on Ustekinumab for Children with Moderate to Severe Crohn's Disease

Neurodermatitis

Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis

Triple negative breast cancer

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.